StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.24+0.01 (+3.94%)

Close on Nov 18, 2026Market cap $3.73MP/E –Yield –

Traws Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Traws Pharma's operating income for the twelve months ending Jun 30, 2026 was -$21.54M. For fiscal 2025 it was -$17.88M. The highest annual figure on record is -$16.50M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.88M–
FY2024Dec 31, 2024-$142.37M–
FY2023Dec 31, 2023-$20.30M–
FY2022Dec 31, 2022-$19.63M–
FY2021Dec 31, 2021-$16.50M–
FY2020Dec 31, 2020-$24.99M–
FY2019Dec 31, 2019-$21.70M–
FY2018Dec 31, 2018-$23.28M–
FY2017Dec 31, 2017-$25.74M–
FY2016Dec 31, 2016-$23.70M–
FY2015Dec 31, 2015-$23.97M–
FY2014Dec 31, 2014-$63.74M–
FY2013Dec 31, 2013-$62.22M–
FY2012Dec 31, 2012-$22.28M–
FY2011Dec 31, 2011-$27.57M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.18M–
Q1 FY2026Mar 31, 2026-$6.95M–
Q4 FY2025Dec 31, 2025-$7.37M–
Q3 FY2025Sep 30, 2025-$4.06M–
Q2 FY2025Jun 30, 2025-$1.25M–
Q1 FY2025Mar 31, 2025-$5.20M–
Q4 FY2024Dec 31, 2024-$5.28M–
Q3 FY2024Sep 30, 2024-$8.54M–
Q2 FY2024Jun 30, 2024-$123.35M–
Q1 FY2024Mar 31, 2024-$5.21M–
Q4 FY2023Dec 31, 2023-$4.46M–
Q3 FY2023Sep 30, 2023-$5.09M–
Q2 FY2023Jun 30, 2023-$4.61M–
Q1 FY2023Mar 31, 2023-$6.14M–
Q4 FY2022Dec 31, 2022-$5.73M–
Q3 FY2022Sep 30, 2022-$5.64M–
Q2 FY2022Jun 30, 2022-$4.12M–
Q1 FY2022Mar 31, 2022-$4.13M–
Q4 FY2021Dec 31, 2021-$3.76M–
Q3 FY2021Sep 30, 2021-$3.99M–
Q2 FY2021Jun 30, 2021-$4.65M–
Q1 FY2021Mar 31, 2021-$4.10M–
Q4 FY2020Dec 31, 2020-$6.26M–
Q3 FY2020Sep 30, 2020-$6.27M–
Q2 FY2020Jun 30, 2020-$7.34M–
Q1 FY2020Mar 31, 2020-$5.13M–
Q4 FY2019Dec 31, 2019-$5.73M–
Q3 FY2019Sep 30, 2019-$5.10M–
Q2 FY2019Jun 30, 2019-$3.63M–
Q1 FY2019Mar 31, 2019-$7.24M–
Q4 FY2018Dec 31, 2018-$6.15M–
Q3 FY2018Sep 30, 2018-$5.59M–
Q2 FY2018Jun 30, 2018-$5.64M–
Q1 FY2018Mar 31, 2018-$5.90M–
Q4 FY2017Dec 31, 2017-$6.12M–
Q3 FY2017Sep 30, 2017-$6.76M–
Q2 FY2017Jun 30, 2017-$6.07M–
Q1 FY2017Mar 31, 2017-$6.79M–
Q4 FY2016Dec 31, 2016-$6.47M–
Q3 FY2016Sep 30, 2016-$4.32M–

More Traws Pharma figures

See a number that looks wrong?